Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Jan 24, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 11.5B USD
- Positions
- 232
- Share of the ten largest
- 45.9%
The ten largest positions Q4 2022
- Exact Sciences Corp 6.9%▼ −8.7%
- Zoom Video Communications Inc 6.2%▼ −2.5%
- Tesla, Inc. 4.9%▲ +13.3%
- Block, Inc. 4.9%▼ −2.1%
- UiPath Inc 4.9%▼ −4.4%
- Roku Inc 4.3%▲ +1.7%
- Shopify 4.0%▼ −8.6%
- Teladoc Health Inc 3.9%▼ −9.3%
- Twilio 3.1%▲ +8.5%
- Intellia Therapeutics Inc 2.8%▼ −2.4%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q4 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Exact Sciences Corp | 6.9% | 16,040,490 | 794.2M USD | −8.7% reduced | Q3 2020 10 quarters |
| Zoom Video Communications Inc | 6.2% | 10,615,891 | 719.1M USD | −2.5% reduced | Q4 2020 9 quarters |
| TSLA Tesla, Inc. | 4.9% | 4,625,472 | 569.8M USD | +13.3% increased | Q4 2016 or earlier 25 quarters |
| XYZ Block, Inc. | 4.9% | 9,003,301 | 565.8M USD | −2.1% reduced | Q4 2016 or earlier 25 quarters |
| UiPath Inc | 4.9% | 44,054,842 | 559.9M USD | −4.4% reduced | Q2 2021 7 quarters |
| Roku Inc | 4.3% | 12,114,981 | 493.1M USD | +1.7% increased | Q2 2019 15 quarters |
| SHOP Shopify | 4.0% | 13,279,103 | 460.9M USD | −8.6% reduced | Q2 2017 23 quarters |
| Teladoc Health Inc | 3.9% | 18,928,440 | 447.7M USD | −9.3% reduced | Q3 2017 22 quarters |
| TWLO Twilio | 3.1% | 7,409,945 | 362.8M USD | +8.5% increased | Q4 2018 17 quarters |
| Intellia Therapeutics Inc | 2.8% | 9,420,782 | 328.7M USD | −2.4% reduced | Q4 2016 or earlier 25 quarters |
| COIN Coinbase | 2.8% | 9,189,273 | 325.2M USD | +19.1% increased | Q2 2021 7 quarters |
| Beam Therapeutics Inc | 2.8% | 8,213,131 | 321.2M USD | −3.3% reduced | Q4 2020 9 quarters |
| CRISPR Therapeutics AG | 2.8% | 7,829,932 | 318.3M USD | −4.9% reduced | Q2 2017 23 quarters |
| Unity Software Inc | 2.7% | 10,972,313 | 313.7M USD | −2.6% reduced | Q3 2020 10 quarters |
| DKNG DraftKings | 2.5% | 25,032,084 | 285.1M USD | +1.3% increased | Q1 2021 8 quarters |
| PagerDuty Inc | 2.3% | 10,097,244 | 268.2M USD | −6.7% reduced | Q1 2020 12 quarters |
| Ginkgo Bioworks Holdings Inc | 2.1% | 144,384,067 | 244.0M USD | +13.9% increased | Q3 2021 6 quarters |
| RBLX Roblox | 2.1% | 8,464,810 | 240.9M USD | −0.1% reduced | Q1 2021 8 quarters |
| HOOD Robinhood Markets | 2.1% | 29,245,424 | 238.1M USD | −11.1% reduced | Q3 2021 6 quarters |
| Pacific Biosciences of Califor | 1.8% | 25,691,681 | 210.2M USD | −10.5% reduced | Q3 2019 14 quarters |
| Veracyte Inc | 1.7% | 8,300,241 | 197.0M USD | −8.6% reduced | Q4 2016 or earlier 25 quarters |
| Twist Bioscience Corp | 1.4% | 6,700,855 | 159.5M USD | +0.4% increased | Q2 2019 15 quarters |
| 10X Genomics Inc | 1.4% | 4,316,567 | 157.3M USD | −5.7% reduced | Q2 2020 11 quarters |
| Ionis Pharmaceuticals Inc | 0.9% | 2,673,538 | 101.0M USD | −28.0% reduced | Q4 2016 or earlier 25 quarters |
| TRMB Trimble Inc. | 0.8% | 1,906,218 | 96.4M USD | −6.2% reduced | Q4 2016 or earlier 25 quarters |
| Verve Therapeutics Inc | 0.7% | 4,365,830 | 84.5M USD | +28.6% increased | Q2 2021 7 quarters |
| Kratos Defense & Security Solu | 0.7% | 7,748,357 | 80.0M USD | −5.4% reduced | Q3 2018 18 quarters |
| Iridium Communications Inc | 0.7% | 1,494,455 | 76.8M USD | −15.5% reduced | Q3 2019 14 quarters |
| NVDA Nvidia | 0.7% | 523,181 | 76.5M USD | −62.2% reduced | Q4 2016 or earlier 25 quarters |
| INCY Incyte | 0.7% | 950,393 | 76.3M USD | −7.7% reduced | Q4 2016 or earlier 25 quarters |
| Schrodinger Inc/United States | 0.6% | 3,852,037 | 72.0M USD | +2.3% increased | Q2 2020 11 quarters |
| CareDx Inc | 0.6% | 6,188,182 | 70.6M USD | +6.9% increased | Q2 2019 15 quarters |
| Adaptive Biotechnologies Corp | 0.6% | 9,201,245 | 70.3M USD | −1.4% reduced | Q2 2020 11 quarters |
| DE Deere & Company | 0.6% | 150,253 | 64.4M USD | −15.0% reduced | Q3 2017 22 quarters |
| MELI MercadoLibre | 0.6% | 75,982 | 64.3M USD | −14.9% reduced | Q4 2016 or earlier 25 quarters |
| Cerus Corp | 0.5% | 15,863,384 | 57.9M USD | −5.9% reduced | Q4 2016 or earlier 25 quarters |
| 2U Inc | 0.5% | 9,166,015 | 57.5M USD | −2.6% reduced | Q4 2016 or earlier 25 quarters |
| AeroVironment Inc | 0.5% | 644,045 | 55.2M USD | −14.1% reduced | Q4 2016 or earlier 25 quarters |
| Grayscale Bitcoin Trust BTC | 0.5% | 6,552,187 | 54.3M USD | +0.9% increased | Q4 2018 17 quarters |
| Invitae Corp | 0.4% | 27,072,844 | 50.4M USD | −11.1% reduced | Q4 2016 or earlier 25 quarters |
| TER Teradyne | 0.4% | 555,038 | 48.5M USD | +0.5% increased | Q4 2016 or earlier 25 quarters |
| Fate Therapeutics Inc | 0.4% | 4,214,863 | 42.5M USD | −63.8% reduced | Q2 2019 15 quarters |
| Accolade Inc | 0.4% | 5,458,916 | 42.5M USD | −7.8% reduced | Q3 2020 10 quarters |
| Discovery Ltd | 0.3% | 4,974,371 | 36.0M USD | −5.8% reduced | Q4 2019 13 quarters |
| Repare Therapeutics Inc | 0.3% | 2,428,055 | 35.7M USD | −7.7% reduced | Q4 2020 9 quarters |
| Komatsu Ltd | 0.3% | 1,641,971 | 35.5M USD | −7.2% reduced | Q3 2019 14 quarters |
| VRTX Vertex Pharmaceuticals | 0.3% | 122,197 | 35.3M USD | −22.4% reduced | Q3 2020 10 quarters |
| Arcturus Therapeutics Holdings | 0.3% | 2,012,429 | 34.1M USD | −7.8% reduced | Q2 2019 15 quarters |
| VEEV Veeva Systems | 0.3% | 211,478 | 34.1M USD | −7.7% reduced | Q4 2020 9 quarters |
| Materialise NV | 0.3% | 3,592,979 | 31.6M USD | −38.7% reduced | Q4 2016 or earlier 25 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 232 positions.
Breakdown by sector
- Financials 9.9%
- Technology 6.0%
- Consumer Discretionary 5.1%
- Health Care 2.1%
- Industrials 1.3%
- Communication Services 0.2%
- not in our coverage 75.5%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors